4,0
8. Okt. 2024
Aktueller Mitarbeiter
South San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
* Great benefits * Great people * Compensation is great with the right team * Benefits are the best in the industry
Kontras
* Pipeline isn't healthy * Leadership is not willing to try something new * Roche oversight makes it difficult to innovate * Company direction isn't always clear * Big company, big politics